Heart failure population health considerations

Patel, Jeenal

doi:10.37765/ajmc.2021.88673

Cited by 14 publications

(4 citation statements)

References 15 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…With prevalence now approaching 2% in the US and Canada and hospitalization rates as high as 3%, it comes as no surprise that $30.7 billion was spent annually in the US alone managing this critical diagnosis. Further, the cost is expected to exceed $70 billion by 2030 [2,3].…”

Section: Introductionmentioning

confidence: 99%

LVAD Continuing Care: A Comprehensive Guide to Long-Term Support and Management

Sobieraj,

Best,

Ahmed

et al. 2024

Cardiology and Cardiovascular Medicine

View full text Add to dashboard Cite

Heart failure is a growing pandemic with a rising societal burden. Heart failure affects 3.6 million people in Europe and 5 million in the United States annually. The United States alone spends 30.7 billion annually managing heart failure, and that number is expected to eclipse 70 billion by 2030. Many people are not orthotopic heart transplant candidates, and many who are may not live long enough to receive a transplant. As a result, durable left ventricular assist devices (LVAD) have become both a bridging therapy and a destination therapy, necessitating a robust continuing care system. LVAD programs are expanding to fill this need. This chapter aims to cover the spectrum of LVAD continuing care from initial implantation to the outpatient clinic. This chapter will cover essential care practices for maintaining LVAD function, including driveline care, battery management, and alarm response/tracking. Troubleshooting the common issues and complications patients might experience, such as low flow alarms, bleeding, infection, and right heart failure. Emphasize the importance of the primary caregiver’s involvement and how to prepare them by providing resources for education, training, and ongoing support. Lastly, it will cover ethical concerns and the role of palliative care in the process.

show abstract

Section: Introductionmentioning

confidence: 99%

LVAD Continuing Care: A Comprehensive Guide to Long-Term Support and Management

Sobieraj,

Best,

Ahmed

et al. 2024

Cardiology and Cardiovascular Medicine

View full text Add to dashboard Cite

show abstract

“…One important cause of the high costs is the high rates of hospitalization. According to the United States Department of Health and Human Services Healthy People 2030, the metric “reduce heart failure hospitalizations” is getting worse rather than better [ 4 ] and few interventions have positively affected hospital readmission rates [ 5 ].…”

Section: Introductionmentioning

confidence: 99%

A snapshot of patient experience of illness control after a hospital readmission in adults with chronic heart failure

et al. 2023

View full text Add to dashboard Cite

Background Approximately 6.5 million adults have chronic heart failure (HF), the number one cause of 30-day hospital readmission. Managing HF and its symptoms is critical for patients. Hospitalization may impact patients’ perceptions of illness control, which can affect illness management. However, how hospital readmissions are perceived as related to one’s ability to control their HF and its symptoms has not been examined. Objective The purpose was to explore the experiences of people with HF in managing their illness (i.e., illness control), understand their perceptions of illness control after recent hospital readmission, and clarify the concept of illness control in people with chronic HF. Methods A qualitative approach, applied thematic analysis was employed. Purposive sampling was used to identify participants. Semi-structured interviews were conducted in 10 participants’ homes. Ongoing, concurrent, and comparative data analysis was used with ATLASti© data management software. Results Two themes were identified, strategies to control HF and barriers to controlling HF. Strategies to control HF included four subthemes: managing dietary intake and medications; self- advocacy; monitoring symptoms; and support. Barriers to control also had four subthemes: healthcare systems issues; health care professional relationships and interactions; personal characteristics; and knowledge deficits. Conclusion People use many different strategies to control HF. Control comes from both within and outside of the individual. The desire to control HF and its symptoms was evident, but implementing strategies is challenging and takes time, experience, and trial and error. Individuals did not view readmission negatively but as necessary to help them control their symptoms.

show abstract

“…Annually in the US there are over 4 million admissions that involve CHF, adding in aggregate $35 billion in direct costs, and accounting for 75–80% of the total annual direct costs associated with CHF care. 3–5 Further raising these costs is the potential for HACs in this disproportionately elderly population. For example, recent analyses suggest that one out of every 13 patients admitted with CHF develops hospital-acquired pneumonia, leading to a substantially elevated subsequent risk of death.…”

Section: Introductionmentioning

confidence: 99%

Descriptive Epidemiology and Outcomes of Patients with Short Stay Hospitalizations for the Treatment of Congestive Heart Failure in the US

Zilberberg¹,

Nathanson²,

Sulham³

et al. 2023

CEOR

View full text Add to dashboard Cite

Background Congestive heart failure (CHF) hospitalizations cost the US $35 billion annually. Two-thirds of these admissions, generally requiring 3 days (long, LLOS) in a cross-sectional multicenter analysis within the 2018 National Inpatient Sample. We applied complex survey methods to calculate nationally representative results. Results Among 4,979,350 discharges with any CHF code, 1,177,910 (23.7%) had CHF-PD, of whom 511,555 (43.4%) had SLOS. Patients with SLOS were younger (>/=65 years: 68.3% vs 71.9%), less likely covered by Medicare (71.9% vs 75.4%), and had a lower comorbidity burden (Charlson: 3.9 [2.1] vs 4.5 [2.2) than patients with LLOS; they less frequently developed acute kidney injury (0.4% vs 2.9%) or a need for mechanical ventilation (0.7% vs 2.8%). A higher proportion with SLOS than with LLOS underwent no procedures (70.4% vs 48.4%). Mean LOS (2.2 [0.8] vs 7.7 [6.5]), direct hospital costs ($6150 [$4413]) vs $17,127 [$26,936]), and aggregate annual hospital costs $3,131,560,372 vs $11,359,002,072) were all lower with SLOS than LLOS. All comparisons reached alpha = 0.001. Conclusion Among patients admitted for CHF, nearly ½ have LOS

show abstract

Heart failure population health considerations

Cited by 14 publications

References 15 publications

LVAD Continuing Care: A Comprehensive Guide to Long-Term Support and Management

LVAD Continuing Care: A Comprehensive Guide to Long-Term Support and Management

A snapshot of patient experience of illness control after a hospital readmission in adults with chronic heart failure

Descriptive Epidemiology and Outcomes of Patients with Short Stay Hospitalizations for the Treatment of Congestive Heart Failure in the US

Contact Info

Product

Resources

About